Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Freeman

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Pain|March 6, 2021
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathyAndrew S C Rice, Robert H Dworkin, Nanna B Finnerup, et al.
Pain Medicine (Malden, Mass.)|October 4, 2024
Personalized outcomes in neuropathic pain: a clinical relevance and assay sensitivity analysis from a randomized controlled trialKarim Saab, Umang Gada, Eva Culakova, et al.
Neurology|July 28, 2017
Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendationsJennifer S Gewandter, Roy Freeman, Rachel A Kitt, et al.
Diabetes Research and Clinical Practice|September 21, 2021
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendationsDan Ziegler, Solomon Tesfaye, Vincenza Spallone, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Nature Reviews. Disease Primers|February 17, 2017
Neuropathic painLuana Colloca, Taylor Ludman, Didier Bouhassira, et al.
Autonomic Neuroscience : Basic & Clinical|March 23, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
Journal of the Peripheral Nervous System : JPNS|November 21, 2023
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patientsPerry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|March 19, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
The Lancet. Neurology|February 11, 2014
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trialPhillip A Low, David Robertson, Sid Gilman, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Pain|March 6, 2021
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathyAndrew S C Rice, Robert H Dworkin, Nanna B Finnerup, et al.
Pain Medicine (Malden, Mass.)|October 4, 2024
Personalized outcomes in neuropathic pain: a clinical relevance and assay sensitivity analysis from a randomized controlled trialKarim Saab, Umang Gada, Eva Culakova, et al.
Neurology|July 28, 2017
Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendationsJennifer S Gewandter, Roy Freeman, Rachel A Kitt, et al.
Diabetes Research and Clinical Practice|September 21, 2021
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendationsDan Ziegler, Solomon Tesfaye, Vincenza Spallone, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Nature Reviews. Disease Primers|February 17, 2017
Neuropathic painLuana Colloca, Taylor Ludman, Didier Bouhassira, et al.
Autonomic Neuroscience : Basic & Clinical|March 23, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
Journal of the Peripheral Nervous System : JPNS|November 21, 2023
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patientsPerry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|March 19, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
The Lancet. Neurology|February 11, 2014
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trialPhillip A Low, David Robertson, Sid Gilman, et al.
Pageof 21